Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.22 Billion CNY | 17.22% |
| 2022 | 7.01 Billion CNY | 14.33% |
| 2021 | 6.13 Billion CNY | 15.64% |
| 2020 | 5.3 Billion CNY | 53.45% |
| 2019 | 3.45 Billion CNY | 30.93% |
| 2018 | 2.64 Billion CNY | 30.59% |
| 2017 | 2.02 Billion CNY | 25.99% |
| 2016 | 1.6 Billion CNY | 39.8% |
| 2015 | 1.14 Billion CNY | 54.01% |
| 2014 | 745.43 Million CNY | 37.8% |
| 2013 | 540.96 Million CNY | 72.77% |
| 2012 | 313.1 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.57 Billion CNY | 4.29% |
| 2024 Q3 | 8.83 Billion CNY | 5.91% |
| 2024 Q2 | 8.34 Billion CNY | -2.71% |
| 2023 Q4 | 8.22 Billion CNY | 6.51% |
| 2023 Q3 | 7.71 Billion CNY | 6.46% |
| 2023 Q2 | 7.25 Billion CNY | -0.09% |
| 2023 FY | 8.22 Billion CNY | 17.22% |
| 2023 Q1 | 7.25 Billion CNY | 3.47% |
| 2022 Q3 | 6.66 Billion CNY | 6.31% |
| 2022 Q2 | 6.26 Billion CNY | -2.0% |
| 2022 FY | 7.01 Billion CNY | 14.33% |
| 2022 Q1 | 6.39 Billion CNY | 4.22% |
| 2022 Q4 | 7.01 Billion CNY | 5.3% |
| 2021 Q1 | 5.5 Billion CNY | 3.71% |
| 2021 Q2 | 5.52 Billion CNY | 0.43% |
| 2021 Q3 | 5.79 Billion CNY | 4.94% |
| 2021 Q4 | 6.13 Billion CNY | 5.8% |
| 2021 FY | 6.13 Billion CNY | 15.64% |
| 2020 FY | 5.3 Billion CNY | 53.45% |
| 2020 Q2 | 5.23 Billion CNY | 48.85% |
| 2020 Q3 | 4.99 Billion CNY | -4.62% |
| 2020 Q4 | 5.3 Billion CNY | 6.17% |
| 2020 Q1 | 3.52 Billion CNY | 1.8% |
| 2019 FY | 3.45 Billion CNY | 30.93% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 3.45 Billion CNY | 0.0% |
| 2018 FY | 2.64 Billion CNY | 30.59% |
| 2017 Q4 | 2.02 Billion CNY | 0.0% |
| 2017 FY | 2.02 Billion CNY | 25.99% |
| 2017 Q2 | 1.62 Billion CNY | 0.0% |
| 2016 Q2 | 1.28 Billion CNY | 0.0% |
| 2016 Q1 | 1.28 Billion CNY | 12.29% |
| 2016 FY | 1.6 Billion CNY | 39.8% |
| 2016 Q3 | 1.6 Billion CNY | 24.5% |
| 2016 Q4 | 1.6 Billion CNY | 0.0% |
| 2015 Q1 | 825.19 Million CNY | 10.7% |
| 2015 FY | 1.14 Billion CNY | 54.01% |
| 2015 Q4 | 1.14 Billion CNY | 0.0% |
| 2015 Q3 | 1.14 Billion CNY | 39.13% |
| 2015 Q2 | 825.19 Million CNY | 0.0% |
| 2014 Q2 | 569.76 Million CNY | 0.0% |
| 2014 Q3 | 745.43 Million CNY | 30.83% |
| 2014 Q1 | 569.76 Million CNY | 5.32% |
| 2014 Q4 | 745.43 Million CNY | 0.0% |
| 2014 FY | 745.43 Million CNY | 37.8% |
| 2013 FY | 540.96 Million CNY | 72.77% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 540.96 Million CNY | 0.0% |
| 2013 Q3 | 540.96 Million CNY | 0.0% |
| 2012 FY | 313.1 Million CNY | 0.0% |